Physician profile
Douglas Allen Prager
NPI 1780666099
$359.57
in general payments reported to CMS, 2019-2025
10 companies · $20.94 in 2025
The $20.94 reported for 2025 was less than what a typical Nuclear Imaging & Therapy provider received nationally (typical 2025 total: $122).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $46.90 · 2021: $11.76 · 2022: $80.70 · 2023: $51.26 · 2025: $20.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $115.17 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $54.79 | 2019-2025 | Naeotom Alpha, Magnetom Skyra, Acuson Sequoia Diagnostic Ultrasound System |
| Novartis Pharmaceuticals Corporation | $44.31 | 2021-2022 | |
| Pfizer INC. | $28.75 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.93 | 2020 | |
| Varian Medical Systems, INC. | $22.43 | 2019 | |
| Telix Pharmaceuticals | $19.40 | 2022 | |
| Daxor Corporation | $18.05 | 2023 | Bva-100 |
| Biocompatibles, INC. | $17.52 | 2019 | |
| Boston Scientific Corporation | $16.22 | 2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Prager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.